Gene · 865
Papers3,690
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 3,690
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DNA-methylation and genomic copy number in primary tumors and corresponding lymph node metastases in prostate cancer from patients with low and high Gleason score. | Clin Transl Radiat Oncol | 2023 | 36935856 | PubTator, text mining | PubMed |
| Timed hazard networks: Incorporating temporal difference for oncogenetic analysis. | PLoS One | 2023 | 36928529 | PubTator, text mining | PubMed |
| Differential regulation of skeletal stem/progenitor cells in distinct skeletal compartments. | Front Physiol | 2023 | 36926193 | PubTator, text mining | PubMed |
| The link between bone-derived factors osteocalcin, fibroblast growth factor 23, sclerostin, lipocalin 2 and tumor bone metastasis. | Front Endocrinol (Lausanne) | 2023 | 36926025 | PubTator, text mining | PubMed |
| Chromosomal Instability as Enabling Feature and Central Hallmark of Breast Cancer. | Breast Cancer (Dove Med Press) | 2023 | 36923397 | PubTator, text mining | PubMed |
| RNA sequencing of myeloid sarcoma, shed light on myeloid sarcoma stratification. | Cancer Med | 2023 | 36916780 | PubTator, text mining | PubMed |
| Understanding the Continuum between High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia. | Int J Mol Sci | 2023 | 36902450 | PubTator, text mining | PubMed |
| The Metabolic Features of Osteoblasts: Implications for Multiple Myeloma (MM) Bone Disease. | Int J Mol Sci | 2023 | 36902326 | PubTator, text mining | PubMed |
| Targeting Measurable Residual Disease (MRD) in Acute Myeloid Leukemia (AML): Moving beyond Prognostication. | Int J Mol Sci | 2023 | 36902217 | PubTator, text mining | PubMed |
| The Landscape of Circular RNAs in Cardiovascular Diseases. | Int J Mol Sci | 2023 | 36902000 | PubTator, text mining | PubMed |
| Exosomes in Colorectal Cancer: From Physiology to Clinical Applications. | Int J Mol Sci | 2023 | 36901813 | PubTator, text mining | PubMed |
| Circular RNA Expression Signatures Provide Promising Diagnostic and Therapeutic Biomarkers for Chronic Lymphocytic Leukemia. | Cancers (Basel) | 2023 | 36900344 | PubTator, text mining | PubMed |
| Current and Emerging Techniques for Diagnosis and MRD Detection in AML: A Comprehensive Narrative Review. | Cancers (Basel) | 2023 | 36900154 | PubTator, text mining | PubMed |
| Identification of Clinically Relevant HIV Vif Protein Motif Mutations through Machine Learning and Undersampling. | Cells | 2023 | 36899908 | PubTator, text mining | PubMed |
| RUNX3 Meets the Ubiquitin-Proteasome System in Cancer. | Cells | 2023 | 36899853 | PubTator, text mining | PubMed |
| TRIB2 safeguards naive T cell homeostasis during aging. | Cell Rep | 2023 | 36884349 | PubTator, text mining | PubMed |
| Therapy-related core binding factor acute myeloid leukemia. | Int J Hematol Oncol | 2023 | 36874378 | PubTator, text mining | PubMed |
| Feasibility of high-throughput drug sensitivity screening (HDS)-guided treatment for children with refractory or relapsed acute myeloid leukemia. | Front Pediatr | 2023 | 36873635 | PubTator, text mining | PubMed |
| Systematic investigation of the underlying mechanisms of GLP-1 receptor agonists to prevent myocardial infarction in patients with type 2 diabetes mellitus using network pharmacology. | Front Pharmacol | 2023 | 36865917 | PubTator, text mining | PubMed |
| MiR-200/183 family-mediated module biomarker for gastric cancer progression: an AI-assisted bioinformatics method with experimental functional survey. | J Transl Med | 2023 | 36864416 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/865/papers?page=18